Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2009-012738-65-IT
EUCTR2009-012738-65-IT
Active, not recruiting
Not Applicable

CLINICAL ACTIVITY OF DNA DAMAGING AND NON-DAMAGING CHEMIOTHERAPY REGIMENS IN ADVANCED BREAST CANCER PATIENTS WITH DIFFERENT BIOLOGICAL SUB-TYPES DEFINED BY BIOMARKERS EVALUATION ON CIRCULATING TUMOR CELLS - CTC PLATINUM

AZIENDA USL 4 PRATO0 sitesMay 19, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMETASTATIC BREAST CANCERMedDRA version: 9.1Level: SOCClassification code 10038604

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
METASTATIC BREAST CANCER
Sponsor
AZIENDA USL 4 PRATO
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 19, 2009
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
AZIENDA USL 4 PRATO

Eligibility Criteria

Inclusion Criteria

  • •ADVANCED BREAST CANCER PATIENTS WHO HAD PROGRESSED ON PRIOR REGIMENS CONTAINING AN ANTRACYCLINE AND/OR TAXANE BASED THERAPY; PATIENTS WITH ECOG PERFORMANCE STATUS OF 0 TO 2; MEASURABLE DISEASE ACCORDING TO RECIST CRITERIA; RENAL, LIVER AND HEMOPOIETIC FUNCTION IN THE LIMITS; PRESENCE OF CTCs IN PERIPHERAL BLOOD SAMPLE; WRITTEN INFORMED CONSENT
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •PRESENCE OF RILEVANT CO\-MORBIDITIES; PREGNANT OR LACTATING WOMEN; ALTERED MENTAL STATUS; CONCURRENT ANTI\-CANCER THERAPIES OTHER THAN STUDY DRUGS

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
To investigate the clinical effect and ctDNA dynamic change of 'Jianpi Lishi Huayu Decoction' on the 'maximum androgen blocking' of advanced prostate cancer
ITMCTR2100004818The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Recruiting
Not Applicable
To investigate the clinical effect and ctDNA dynamic change of 'Jianpi-Lishi-Huayu Decoction' on the 'maximum androgen blocking' of advanced prostate cancer
ITMCTR2100004504The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Not yet recruiting
Not Applicable
A clinical trial to study the prediction of result of chemotherapy in Acute myeloid leukemia by evaluating in vitro DNA damage.
CTRI/2010/091/000015Dr. KH Reeta,Assistant professorDepartment of PharmacologyAIIMS, New Delhi-11002930
Recruiting
Not Applicable
Clinical efficacy of ctDNA dynamics before and after total neoadjuvant treatment in locally adjuvant rectal cancer.
KCT0008155Chonnam National University Hospital Hwasun Hospital45
Recruiting
Not Applicable
Circulating DNA for treatment and follow-up in squamous cell cancerssquamous cell cancers
DRKS00031154Asklepios Tumorzentrum Hamburg600